Clinical Trial Update: High-dose FOLFIRI in Advanced Colorectal Cancer Patients With Wild-type UGT1A1*6 and *28 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating high-dose FOLFIRI in adults with advanced colorectal cancer who carry wild-type UGT1A1*6 and *28 genotypes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• FOLFIRI (folinic acid/5-fluorouracil/irinotecan) (folinic acid + 5-fluorouracil + irinotecan)
• Folinic acid (Leucovorin) (folinic acid)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN